CIK: 0001802967 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value ($000): $435,771 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Ouster, Inc. | 11,253,152 | $140,552 | 32.3% | $8.50 | — | Common Stock | 68989M103 |
| TWST | Twist Bioscience Corporation | 828,815 | $110,440 | 25.3% | $23.40 | +396.8% | Common Stock | 90184D100 |
| UBER | Uber Technologies, Inc. | 1,284,851 | $64,397 | 14.8% | $30.07 | +73.7% | Common Stock | 90353T100 |
| TSLA | Tesla, Inc. | 57,500 | $39,083 | 9.0% | $78.42 | +176.8% | Common Stock | 88160R101 |
| IS5EUR | ironSource Ltd. | 3,704,460 | $38,897 | 8.9% | $10.50 | — | Class A Ordinary Shares | M5R75Y101 |
| MASS | 908 Devices Inc. | 568,981 | $22,049 | 5.1% | $58.41 | -22.5% | Common Stock | 65443P102 |
| — | Zymergen Inc. | 247,690 | $9,911 | 2.3% | $40.01 | — | Common Stock | 98985X100 |
| H | Hyatt Hotels Corporation | 70,000 | $5,435 | 1.2% | $76.75 | +4.0% | Class B Common Stock | 448579102 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 51,396 | $5,007 | 1.1% | $108.57 | +9.0% | Common Stock | 558868105 |